The population impact of human papillomavirus vaccination on circulating genotypes

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1007685

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Infection with human papillomavirus (HPV) is very common. Persistent infection can cause abnormal changes to cervical cells as found on Pap smears and if untreated, over time can develop into cervical cancer. Recently, a vaccine was introduced in Australia for women aged 12-26. To monitor the effectiveness of this vaccine, young women aged 18-22 will be asked to self-collect a sample for HPV detection which will determine if HPV types targeted by vaccine are reducing in prevalence.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2013

Funding Scheme: NHMRC Project Grants

Funding Amount: $249,259.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Health Information Systems (incl. Surveillance)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cervical cancer | cervical carcinoma | cervical precancer | genotype | high risk | human papillomavirus (HPV) | papillomavirus infection | persistence | vaccine efficacy | vaccines

Related Links